background image

Paid Clinical Trials New Hampshire

Discover 329 paid clinical trials in New Hampshire. Search by city or condition to find a research study near you that matches your needs across various therapeutic areas.

Filter
1

A Study to Evaluate Etrasimod Treatment in Adolescents With Ulcerative Colitis

Recruiting
PHASE2

Sponsor:

Pfizer

Location:

Lebanon NH, Boston MA, Rochester NY, Cleveland OHshow 14 more

Code:

NCT05287126

Conditions

Ulcerative Colitis

Eligibility Criteria

Sex: All

Age: 12 - 17

Healthy Volunteers: Not accepted

Interventions

Etrasimod

Study of Trilaciclib and Lurbinectidin

Recruiting
PHASE2

Sponsor:

UNC Lineberger Comprehensive Cancer Center

Location:

Lebanon NH, Chapel Hill NC

Code:

NCT05578326

Conditions

Lung Cancer

Small-cell Lung Cancer

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Trilaciclib

Lurbinectedin

To Evaluate Efficacy and Safety of Serplulimab + Chemotherapy (Carboplatin- Etoposide) in US Patients With ES-SCLC

Recruiting
PHASE3

Sponsor:

Shanghai Henlius Biotech

Location:

Lebanon NH, Burlington MA, Boston MA, Providence RIshow 85 more

Code:

NCT05468489

Conditions

Extensive Stage Small Cell Lung Cancer

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Serplulimab + chemotherapy (carboplatin-etoposide)

Atezolizumab + chemotherapy (carboplatin-etoposide)

Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25

Recruiting
PHASE3

Sponsor:

NRG Oncology

Location:

Concord NH, Manchester NH, Lebanon NH, Newburyport MAshow 706 more

Code:

NCT05879926

Conditions

Breast Cancer

Eligibility Criteria

Sex: Female

Age: 18 - 60

Healthy Volunteers: Not accepted

Interventions

Ovarian Function Suppression + Aromatase Inhibitor

Adjuvant Chemotherapy + Ovarian Function Suppression

A Phase 1 Study of CPO301 in Adult Patients With Advanced or Metastatic Solid Tumors

Recruiting
PHASE1

Sponsor:

Conjupro Biotherapeutics, Inc.

Location:

Lebanon NH, Philadelphia PA, Toronto, Hamiltonshow 9 more

Code:

NCT05948865

Conditions

Cancer

Cancer, Lung

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

CPO301

PROMISE III: Percutaneous Deep Vein Arterialization for the Treatment of Late-Stage Chronic Limb-Threatening Ischemia

Recruiting

Sponsor:

LimFlow, Inc.

Location:

Lebanon NH, Boston MA, Worcester MA, New Haven CTshow 21 more

Code:

NCT05313165

Conditions

Critical Limb Ischemia

Chronic Limb-Threatening Ischemia

Peripheral Arterial Disease

Eligibility Criteria

Sex: All

Age: 18 - 70+

Healthy Volunteers: Not accepted

Interventions

LimFlow Stent Graft System

A Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986278 in Participants With Idiopathic Pulmonary Fibrosis

Recruiting
PHASE3

Sponsor:

Bristol-Myers Squibb

Location:

Boston MA, Springfield MA, Sherbrooke, New Haven CTshow 87 more

Code:

NCT06003426

Conditions

Idiopathic Pulmonary Fibrosis

Eligibility Criteria

Sex: All

Age: 40+

Healthy Volunteers: Not accepted

Interventions

BMS-986278

BMS-986278 Placebo

OCT in Open Fracture and Infected Fracture

Recruiting

Sponsor:

Dartmouth-Hitchcock Medical Center

Location:

Lebanon NH

Code:

NCT05785182

Conditions

Trauma Injury

Trauma

Open Fracture

Fracture Infection

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Open Fracture

Infected Fracture

A Study to Evaluate the Efficacy and Safety Study of Povorcitinib in Participants With Prurigo Nodularis (STOP-PN2)

Recruiting
PHASE3

Sponsor:

Incyte Corporation

Location:

Portsmouth NH, Brighton MA, Bronx NY, Hackensack NJshow 47 more

Code:

NCT06516965

Conditions

Prurigo Nodularis

Eligibility Criteria

Sex: All

Age: 18 - 70+

Healthy Volunteers: Not accepted

Interventions

Povorcitinib

Placebo

SPYRAL AFFIRM Global Study of RDN with the Symplicity Spyral RDN System in Subjects with Uncontrolled HTN

Recruiting

Sponsor:

Medtronic Vascular

Location:

Lebanon NH, Boston MA, Burlington VT, Providence RIshow 66 more

Code:

NCT05198674

Conditions

Hypertension

Vascular Diseases

Cardiovascular Diseases

Chronic Kidney Diseases

Diabetes Mellitus

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Renal Denervation (Symplicity Spyral™)

Popular cities in New Hampshire

New Hampshire stands out as a key location for clinical trials, thanks to its strong healthcare network and renowned medical research institutions. Dartmouth-Hitchcock Medical Center and the Geisel School of Medicine at Dartmouth are at the forefront of innovative studies, particularly in areas such as cancer, cardiovascular diseases, and neurological conditions.

With access to cutting-edge medical technology and expertise, these institutions contribute significantly to groundbreaking advancements in medical research.

Why choose New Hampshire for clinical trials?

Common conditions studied in New Hampshire

Local regulations and guidelines

Benefits of participating in clinical trials

How to enroll in a clinical trial in New Hampshire